ALDESTA 7.5mg 7.5mg/ml solution for injection in pre-filled syringe ADDENDA PHARMACEUTIC
methotrexate Indicated for: cancer; autoimmune inflammatory diseases
letter A · page 32
methotrexate Indicated for: cancer; autoimmune inflammatory diseases
laronidase Indicated for: lysosomal enzyme deficiency
laronidase Indicated for: lysosomal enzyme deficiency
alectinib Indicated for: non-small cell lung cancer
levodopa + carbidopa Indicated for: Parkinson's disease
N04BA02 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa Indicated for: Parkinson's disease
N04BA02 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
alendronic acid Indicated for: osteoporosis
chromoglic acid Indicated for: allergic rhinitis; urticaria
S01GX01 Sensory organs | Decongestants and antiallergics | Other antiallergics
chloropyramine Indicated for: allergic rhinitis; urticaria
cetirizine Indicated for: allergic rhinitis; urticaria
loratadine Indicated for: allergic rhinitis; urticaria
ropinirole Indicated for: Parkinson's disease
N04BC04 Nervous system | Dopaminergic agents | Dopamine agonists
ropinirole Indicated for: Parkinson's disease
N04BC04 Nervous system | Dopaminergic agents | Dopamine agonists
ropinirole Indicated for: Parkinson's disease
N04BC04 Nervous system | Dopaminergic agents | Dopamine agonists
ropinirole Indicated for: Parkinson's disease
N04BC04 Nervous system | Dopaminergic agents | Dopamine agonists
ropinirole Indicated for: Parkinson's disease
N04BC04 Nervous system | Dopaminergic agents | Dopamine agonists
levonorgestrel Indicated for: contraception
naproxen Indicated for: pain and inflammation
cytarabine Indicated for: cancer
L01BC01 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
cytarabine Indicated for: cancer
L01BC01 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues